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1. Introduction 
Cathepsin B belongs to a group of proteolytic 
enzymes whose active sites involve an SH-group. The 
enzyme was purified and described first by Fruton 
who observed that cathepsin B cleaves benzoyl-arginine 
amide, a trypsin substrate, in the presence of cysteine 
[ I ] . A detailed procedure for the purification of the 
enzyme was reported by Greenbaum and Fruton [2]. 
These authors also found other activators and inhibi- 
tors of this enzyme. They were able to activate cathep- 
sin B by dimercaptopropanol, mercaptoethanol and 
glutathione while inhibition could be achieved by io- 
dacetamide, HgCl, and partly also by p-chloromer- 
curibenzoate. By contrast, cathepsin B is not inhibited 
either by diisopropyl-fluorophosphate or by soy-bean 
trypsin inhibitor. Similarly to trypsin, cathepsin B 
cleaves benzoyl-arginine amide and benzoyl-lysine 
amide. It does not hydrolyze, however, the simpler 
substrates of trypsin, such as L-arginine amide or 
Larginine methyl ester. Cathepsin B activates tryp- 
sinogen to trypsin and catalyzes transamidation reac- 
tions [3] . 
This part of our more extensive study on cathep- 
sins, predominantly on their specificity, was aimed 
at the isolation of homogeneous cathepsin B and at the 
determination of the specificity of cleavage of a poly- 
peptide substrate, the B-chain of oxidized insulin, by 
this enzyme. 
2. Material and methods 
As starting material for the preparation of cathep- 
sin B served the beef spleen acetone powder [4] which 
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was extracted with 0.01 M phosphate buffer at pH 6. 
2.1. Precipitation with ammonium sulfate 
The phosphate extract was centrifuged and the 
supernatant was saturated to 105% of saturation with 
ammonium sulfate. The precipitate was removed and 
the supernatant was adjusted to 75% saturation with 
ammonium sulfate. The precipitate formed was dis- 
solved in a minimum volume of water and the bulk of 
ammonium sulfate was removed by dialysis against 
water. 
2.2. Chromatography on CM-sephadex C-25. 
The material was equilibrated with 0.01 M phos- 
phate buffer at pH 6.1 by passage over a column of 
BioCel P-l 0 and then chromatographed on a CM- 
sephadex column equilibrated with the same buffer. 
Under these conditions all proteolytically active com- 
ponents emerged in the first peak and the largest por- 
tion of contaminating proteins remained adsorbed on 
the resin. 
2.3. Chromatography on DEAE-sephadex A-SO 
The active fraction was chromatographed on a 
DEAE-sephadex A-50 column equilibrated with 
0.01 M phosphate at pH 6.4. The fraction which 
cleaved benzoyl-arginine-p-nitranilide was present 
both in the first peak and also in the material eluted 
by 0.1-0.2 M NaCl. The first fraction contained in 
addition to cathepsin B the bulk of cathepsin D 
present in the original mixture. Therefore only the 
material emerging as the second peak was treated 
further. 
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2.4. Gel filtration 
High molecular weight proteins and a part of 
cathepsin D were removed by gel filtration through a 
Sephadex G-100 column equilibrated with 0.01 M phos- 
phate buffer at pH 7.5. 
2.5. Rechromatography on DEAE-sephadex A-50 
The column was equilibrated with 0.01 M phosphate 
at pH 7.5. The rest of cathepsin D was eluted by 0.1 M 
NaCl under these conditions while cathepsin B emerged 
in 0.2 M NaCl. This material, rich in cathepsin B, was 
subjected to one additional rechromatography run 
under the same conditions. Cathepsin B was eluted 
again by 0.2 M NaCl and emerged as a sharp peak 
containing only one proteolytically active fraction. 
26. Assay of proteolytic activity 
(1) The 1% solution (1 ml) of hemoglobin which 
had been urea-denaturated in the McIlvain buffer at 
pH 3.8 and the enzyme solution (0.2 ml) were incu- 
bated for 1 hr at 37”. After the addition of 3 ml of 
5% trichloroacetic acid to the incubation mixture, the 
precipitate formed was filtered off and the absorbance 
of the filtrate at 280 pm was measured. 
(2) A mixture containing 0.4 ml of the benzoyl- 
arginine-p-nitranilide solution (1 mg/l ml Hz(I), 
0.4 ml of 0.2 M phosphate buffer containing 0.04 M 
cysteine at pH 5.2 and 0.4 ml of the enzyme solution 
was incubated for 2 hr at 37”. The amount of p-ni- 
tranilide liberated was determined spectrophotometri- 
tally at 410 mp. 
Disc-electrophoresis in polyacrylamide gel was 
carried out according to Davis [5]. 
2.7. Molecular weight determination 
The molecular weight was calculated from the 
elution volume in which the enzyme emerged from 
a Bio-Gel P-60 column equilibrated with 0.01 M 
acetate buffer at pH 4.5, either in the presence of 
0.04 M cysteine or in the absence of cysteine. As 
standard samples ribonuclease, ovalbumin, and serum 
albumin were used. 
The N-terminal end group was determined by the 
Edman degradation technique [6]. 
2.8. Digestion of B-chain of oxidized insulin 
The B-chain (40 mg) of oxidized insulin was dis- 
solved in 0.05 M trimethylamine acetate buffer at 
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pH 5.2 containing 0.04 M cysteine. The digestion with 
cathepsin B was allowed to proceed for 8 hr at 37”. 
The digest was lyophilized and cysteine from the buffer 
was oxidized by performic acid to cysteic acid. The 
material was then applied to a Dowex 50-X2 column 
equilibrated at 25” with pyridine formate buffer at 
pH 3.0. The peptides were eluted by buffers of in- 
creasing molarity and pH. Aliquots of the tluates 
were examined by paper chromatography in the sys- 
tem pyridine-n-butanol-acetic acid-water (10: 15: 3: 12). 
The mixture of peptides was fractionated by paper 
electrophoresis or by high voltage electrophoresis at 
4,000 V. Qualitative and quantitative amino acid 
analyses of peptides were performed on an amino acid 
analyzer according to Spackmann, Moore and Stein. 
3. Results and discussion 
It has been shown by Bouma and Gruber [7] that 
spleen represents a very rich source of cathepsin B. 
The ability of this enzyme to cleave the trypsin sub- 
strate, benzoyl-arginine-p-nitranilide, in the presence 
of cysteine enables us to isolate selectively this enzyme 
from the mixture of other proteolytic enzymes which 
show different specificities. When the purest cathepsin 
B preparation, which we obtained by systematic frac- 
tionation based on this specific test, was subjected to 
disc-electrophoresis in polyacrylamide gel at pH 8.4, 
the presence of the main zone and of one additional 
minor zone was observed. Additional rechromatography 
did not increase the purity of the preparation which, 
on the contrary, was sometimes even more heteroge- 
neous, most likely ‘due to partial autolysis during the 
experiment. The purest preparation of cathepsin B 
showed the presence of two N-terminal amino acids, 
i.e. of isoleucine and valine at an approximately equi- 
molar ratio. This finding seems to suggest he exis- 
tence of two polypeptide chains linked together by 
disulfide bonds. When subjected to gel filtration on 
Bio-Gel P-60 in the absence of cysteine, cathepsin B 
gives two active components of molecular weight 
24,000 and 40,000. In the presence of 0.04 M 
cysteine the equilibrium is shifted significantly in 
favor of the component of lower molecular weight. 
The two components do not differ in the value of 
pH of optimum cleavage of the specific substrate nor 
in their behaviour during the interaction with inhibitors. 
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Fig. 1. Degree of hydrolysis of the B-chain of oxidized insulin 
with cathepsin B and papain. 
Hence, the components probably represent two dif- 
ferent quaternary structures of the same active enzyme 
whose existence is based on the reactivity of SH-groups. 
Greenbaum and Fruton [2] found that the optimum 
pH for the cleavage of benzoyl-arginine amide by cathep 
sin B lies between pH 4.2 and 5.8. The pH optimum of 
cleavage of a similar substrate, benzoyl-arginine-p- 
nitranilide, by our enzyme preparation, was between 
pH 5 and 6. It has been shown that cathepsin B cleaves 
still other synthetic substrates such as e.g. leucyl- 
leucyl-pnitranilide. This rather broad specificity of 
cathepsin B resembles that of papain. Another feature 
in common is the presence of an SH-group at the 
active site. 
In an effort to elucidate the function of cathepsin 
B in more detail we assayed its specificity toward the 
B-chain of oxidized insulin as substrate and compared 
the specificity with that of papain toward the same 
substrate as reported by Johansen et al. [8]. As can 
be seen in fig. 1, the specificity of cathepsin B is 
rather broad and resembles that of papain. The main 
sites of cleavage are at the carboxyl side of glycine, 
alanine, leucine and glutamic acid. A fact deserving 
interest is that cathepsin B cleaves readily a simple 
substrate, i.e. benzoyl-arginine-p-nitranilide or amide 
while the bond Arg-Gly in the B-chain of oxidized 
insulin is cleaved only very little. The same holds true 
for papain. 
The difference in the mode of cleavage of a simple 
synthetic substrate and of a polypeptide substrate 
can be confronted with the data reported by Gerwin, 
Stein and Moore [9] and by Schechter and Berger 
[lo] . According to these and other authors [ 1 l] the 
cleavage is affected not merely by the nature of the 
two residues which form the given bond but also by 
other amino acid residues distant from the cleaved 
bond. Thus, e.g. the streptococcal proteinase cleaves 
preferentially the bond X-Y if X ispr,eceded by a hy- 
drophobic amino acid residue [9] . A similar obser- 
vation was made with papain. Schechter and Berger 
were able to show that the peptide X.Phe.Y.Z is a 
good substrate for papain. The phenylalanyl residue 
does not participate in the cleaved bond but it is in 
the close environment of the amino acid residue at 
whose carboxyl side the papain cleavage takes place. 
The substrate X.Phe.Z can be bound by the enzyme 
but it is not cleaved and acts as a competitive inhi- 
bitor. 
The fact that cathepsins like other proteinases 
can “perceive” in the substrate amino acids which are 
located at a considerable distance from the cleaved 
bond has been observed by us [ 1 l] with cathepsin D. 
When we substituted individual amino acids of the 
substrate by the corresponding D-amino acids we were 
able to show that a D-amino acid which is located 
four residues apart from the cleaved peptide bond 
(with respect to the carboxyl-terminal end of the 
peptide) can inhibit by 95% the cleavage of the pep- 
tide. It would thus appear that the binding site as 
regarded with respect to the carboxyl end of the given 
peptide involves at least four amino acid residues. 
The situation may become even more complicated 
with polypeptide substrates, such as the B-chain of 
insulin, where the arising peptides can act as inhibitors 
by blocking the binding site of the enzyme. 
The results of our studies on the specificity of 
cathepsin B cleavage do not permit as yet its regulari- 
ties to be defined in such detail as with papain. A fact 
which in our opinion deserves consideration from a 
general biological point of view is 'the existence of 
such considerable similarities in the enzymatic proper- 
ties of proteinases isolated from streptococci, from 
a plant, and from animal sources. A more detailed 
study on the specificity of cathepsin B may in future 
provide evidence in favor of the hypothesis postulat- 
ing the existence of similarities in the structure of 
binding sites and active sites of proteinases isolated 
from species which are very distant from a genetic 
and evolutionary point of view. 
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